In view of the above research basis and the results of mining and summarizing this study in the database, we speculate that RBM8A may act indirectly on immune checkpoints and immune-infiltrating cells through the STAT3 signaling pathway and p53 signaling pathway to affect tumor immunotherapy. The gene discussed is STAT3; the disease is neoplasm.